Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 2,080 | 244.965 | 509,527 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 2,079 | 244.4509 | 508,213 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,693 | 136.9089 | 505,605 | I |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,800 | 280.66 | 505,188 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 2,204 | 228.7893 | 504,252 | I |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 2,190 | 213.8548 | 468,342 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 1,600 | 290.36 | 464,576 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,672 | 274.57 | 459,081 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 1,821 | 246.3097 | 448,530 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,877 | 153.2523 | 440,907 | I |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,549 | 283.85 | 439,684 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,994 | 145.9775 | 437,057 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,144 | 136.1805 | 428,151 | I |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,658 | 156.4244 | 415,776 | I |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 1,600 | 257.9347 | 412,696 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,500 | 272.74 | 409,110 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 1,653 | 246.0123 | 406,658 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,476 | 269.61 | 397,944 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 2,124 | 187.2439 | 397,706 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 1,643 | 240.1076 | 394,497 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,804 | 214.6815 | 387,285 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 1,558 | 246.1302 | 383,471 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 1,769 | 216.6683 | 383,286 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 1,460 | 258.2834 | 377,094 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,300 | 275.53 | 358,189 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 1,467 | 243.0005 | 356,482 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 1,441 | 242.9523 | 350,094 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 1,420 | 240.0979 | 340,939 | D |
14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 13 Dec 2023 | Sale | 1,500 | 225 | 337,500 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 1,847 | 181.93 | 336,025 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,228 | 146.2104 | 325,757 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,100 | 279.46 | 307,406 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 1,343 | 226.971 | 304,822 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,107 | 267.47 | 296,089 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 1,217 | 243.2823 | 296,075 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,363 | 212.8513 | 290,116 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 1,660 | 173.7481 | 288,422 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,000 | 280.92 | 280,920 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 1,528 | 174.8748 | 267,209 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 1,195 | 219.241 | 261,993 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,385 | 186.593 | 258,431 | I |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 900 | 271.03 | 243,927 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,291 | 188.7029 | 243,615 | I |
18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 15 Dec 2023 | Sale | 1,000 | 241 | 241,000 | D |
23 May 2024 21:36 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 21 May 2024 | Sale | 1,036 | 231.34 | 239,668 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,100 | 217.8553 | 239,641 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 829 | 285.15 | 236,389 | D |
18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 15 Dec 2023 | Sale | 1,000 | 236 | 236,000 | D |
18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Dec 2023 | Sale | 1,000 | 233 | 233,000 | D |
18 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Dec 2023 | Sale | 1,000 | 232 | 232,000 | D |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 945 | 244.7881 | 231,325 | D |
06 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 05 Dec 2023 | Sale | 1,000 | 227.33 | 227,330 | D |
14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 13 Dec 2023 | Sale | 1,000 | 226 | 226,000 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 1,206 | 185.865 | 224,153 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 811 | 275.7 | 223,593 | D |
06 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 04 Dec 2023 | Sale | 1,000 | 221.38 | 221,380 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 841 | 262.1797 | 220,493 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 1,000 | 218.9945 | 218,994 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 800 | 271.27 | 217,016 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 1,147 | 188.8359 | 216,595 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 925 | 227.857 | 210,768 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,117 | 188.4649 | 210,515 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 800 | 262.005 | 209,604 | D |
01 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 30 Nov 2023 | Sale | 1,000 | 206.73 | 206,730 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 842 | 243.2559 | 204,821 | D |
01 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 30 Nov 2023 | Sale | 1,000 | 204 | 204,000 | D |
01 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 30 Nov 2023 | Sale | 1,000 | 203 | 203,000 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,076 | 188.3232 | 202,636 | I |
01 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 29 Nov 2023 | Sale | 1,000 | 198.4 | 198,400 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 700 | 277.83 | 194,481 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 700 | 276.67 | 193,669 | D |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 15 Nov 2023 | Purchase | 1,181 | 161.966 | 191,282 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 700 | 270.25 | 189,175 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 713 | 265.2809 | 189,145 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 869 | 217.5152 | 189,021 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 1,107 | 168.7825 | 186,842 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 700 | 265.3557 | 185,749 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 1,291 | 142.8575 | 184,429 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 737 | 247.1385 | 182,141 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 818 | 216.6994 | 177,260 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 1,142 | 154.7801 | 176,759 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 711 | 247.2268 | 175,778 | D |
14 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Dec 2023 | Sale | 800 | 219 | 175,200 | D |
06 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 04 Dec 2023 | Sale | 800 | 215.73 | 172,584 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 978 | 174.6698 | 170,827 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 700 | 241.1413 | 168,799 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 600 | 277.91 | 166,746 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 738 | 222.676 | 164,335 | I |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 903 | 175.8179 | 158,764 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 593 | 266.04 | 157,762 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 721 | 216.9838 | 156,445 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 627 | 244.3138 | 153,185 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 500 | 296.68 | 148,340 | D |
10 Apr 2024 20:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 08 Apr 2024 | Sale | 600 | 246.9773 | 148,186 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 612 | 241.1478 | 147,582 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 539 | 273.48 | 147,406 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 708 | 205.6 | 145,565 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 668 | 214.7223 | 143,434 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 567 | 246.2028 | 139,597 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 648 | 212.0414 | 137,403 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)